Promoting weight agnostic total cardiometabolic health using the physical activity for the heart intervention: the watch-PATH trial - only 13% of adults with obesity meet physical activity (PA)…
Active Grant Awarded
- Award ID
- R01NR022430
- Recipient
-
Emory University UEI S352L5PJLMP8
- Awarding agency
-
National Institute of Nursing Research
National Institutes of Health, Department of Health and Human Services
- Obligated
- $678,031
Award facts
- Assistance listing
- 93.361 Nursing Research
- Completion date 4% complete
- Place of performance
- Atlanta, GA 30322, USA
Award details come from USAspending.gov.
About this award
The National Institute of Nursing Research, part of the National Institutes of Health within the Department of Health and Human Services, awarded Emory University's Office of Sponsored Programs a grant under Assistance Listing 93.361, Nursing Research, with $678,031 obligated on September 9, 2026. Grant R01NR022430 funds a 12-month randomized controlled trial of Physical Activity for the Heart (PATH), a weight-neutral web-based program co-created with adults with obesity. PATH uses YouTube to curate preferred workout videos and pairs them with remote coaching that provides personalized feedback. The trial randomizes 300 adults with obesity equally to PATH or an attention control, with blinded outcome assessment and a prespecified intention-to-treat analysis.
Aim 1 assesses efficacy for physical activity adherence and maintenance across the obesity spectrum. Its primary endpoints are change in weekly MVPA and daily step count at 6 and 12 months, and key secondary endpoints are the proportion of participants meeting physical activity guidelines and attaining 7,500 steps per day. Aim 2 examines mechanistic effects on biological pathways associated with cardiovascular disease risk at 6 and 12 months. The investigators hypothesize that PATH will increase adiponectin and reduce interleukin-1B, with these changes accompanying improvements in body composition and blood pressure.
Work is performed in Atlanta, Georgia 30322, USA. The period of performance runs from the September 9, 2026 award date to an ultimate completion date of June 30, 2031. The assistance type is a grant.
Description
Promoting weight agnostic total cardiometabolic health using the physical activity for the heart intervention: the watch-PATH trial - only 13% of adults with obesity meet physical activity (PA) guidelines, despite substantial cardiovascular disease risk. Adults with obesity face complex barriers including discomfort exercising in public spaces, joint pain, poor fitness, and low self-efficacy. Existing web-based interventions show limited efficacy due to lack of behavioral coaching and generic content. Adults with obesity prefer programs that are convenient, enjoyable, and feature relatable individuals. Yet, interventions intentionally designed to incorporate these preferences are rare. We developed physical activity for the heart (PATH), a weight-neutral web-based program CO-created with adults with obesity that leverages youtube to curate preferred workout videos and employs remote coaching with personalized feedback. Our pilot studies demonstrate excellent feasibility, retention, engagement, and preliminary efficacy over three to six months. However, whether the platform promotes long-term PA adoption and improves cardiometabolic health remains unknown. We will conduct a 12-month randomized controlled trial with 300 adults with obesity randomized equally to PATH intervention or attention control, with blinded outcome assessment and prespecified intention-to-treat analysis. Aim 1 will assess efficacy for PA adherence and maintenance across the obesity spectrum; the primary endpoints are change in weekly mvpa and daily step count at 6 and 12 months, with the proportion of participants meeting the PA guidelines and attaining ≥7,500 steps/day as key secondary endpoints. Aim 2 will elucidate mechanistic effects on biological pathways associated with cardiovascular disease risk at 6 and 12 months. We hypothesize that PATH will increase adiponectin and reduce interleukin-1Β, and that these changes will accompany improvements in body composition, blood pressure, and 10-year absolute CVD risk at 6 and 12 months. Aim 3 will investigate whether intervention-induced changes in psychological constructs (self-efficacy, self-regulation, PA enjoyment, social support, outcome expectancy) mediate PATH effects on PA outcomes. An exploratory aim will examine associations between objectively logged intervention engagement (platform usage, coaching attendance, self-monitoring) and PA outcomes within the PATH group. Diet quality is measured in both arms and modeled as a covariate. If efficacious, PATH could offer primary care practices and post-rehabilitation programs a referral option for sustaining PA in adults with obesity. The study will provide insights into behavioral mechanisms through which weight-neutral programs promote PA and physiological mechanisms underlying their impact on cardiometabolic health in obesity.
Quick answers
Who received award R01NR022430?
R01NR022430 was awarded to Emory University by National Institute of Nursing Research (National Institutes of Health) on September 9, 2026.
How much is award R01NR022430 worth?
$678,031 has been obligated on R01NR022430.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award